Can low-grade toxicities have a greater impact on patients than we realize? #ASCO26@BethN01@ASCO
Let’s explore how patient-reported experiences and long-term treatment effects may shape decision regret following adjuvant pembrolizumab in RCC
https://t.co/5HFi9yPGBe
📢 YSIOG is pleased to invite our community to the upcoming Geri-Onc Study Day:
Ageing and Oncology: Smarter Cancer Care for Older Adults
📍 Manchester
🗓️ 8 June
💻 Hybrid format — open to colleagues joining remotely, including non-UK participants.
#YSIOG#GeriOnc
Super excited that the @CUCancerCenter now has a webpage highlighting how we care for older adults with cancer!
Personalized, multidisciplinary, and focused on what matters most to patients 💪
Check it out 👇
https://t.co/HA9AxvdaEM
New paper in @NatRevClinOncol !
We propose “time budgeting” as a new design principle for cancer care: treating patient time as a finite resource that should be measured, protected, and incorporated into care pathways & clinical trials.
Because time is also a toxicity. ⏳
More takeaways that will stay w me @SIOGorg
🔹 @melissalow inspiring talk on integrating patients into GO research
🔹 @vani_katheria excellent insights on optimizing clinical trial performance
🔹 @GrantWilliamsMD powerful reminder of why we need trials designed 4 older adults
So grateful for 3 intensive days @SIOGorg Masterclass
I had the honor of speaking about clinical research in low-resource settings and highlighting key resources like the @ASCO guidelines
Incredibly inspiring discussions on how we can make research more feasible and impactful
Functionomics in DLBCL 🏃♀️💪
Do you treat older pts with DLBCL?
If so, please consider taking this survey- https://t.co/GLuGveGlwv
15 min of your time will help us understand if/how fitness is being incorporated in decision making. 🙏
#geriheme#gerionc#lymsm
SIOG is launching #IGOR, a new resource to map data sources that combine #cancer and geriatric variables — supporting collaboration and stronger research in #GeriatricOncology.
If you manage or know of a relevant database, we invite you to contribute:
🔗 https://t.co/S9a50oEff0
📢 Got access to datasets with both #cancer‑related and geriatric variables?
Population-based, hospitalisation data, cohort studies—anything counts!
Your dataset could significantly boost geriatric #oncology research.
👉 Contribute to IGOR resource!!
Mentorship that multiplies means making science viable
Joining this panel on intentional networks and on turning ideas into relevant research, structuring manuscripts, responding to reviewers...
@ASCO@thenasheffect@RyanNipp@IshwariaMD@NazliDizman@cspramesh